TipHub

383.95

+1.61 +0.42%

As of 30 Jul 2026 · delayed

NSE Listed · Pharmaceuticals

Gufic BioSciences Ltd. (GUFICBIO)

Volume: 32,344Avg Vol 1W: 46,193Avg Vol 1M: 1,30,94052W Range:268448
Market Cap₹3,835 Cr
Current Price₹383.95
Previous Close₹382.34
High / Low (52w)₹448 / ₹268
Volume32,344
Avg Vol (1W)46,193
Avg Vol (1M)1,30,940
Stock P/E176.12
Book Value₹66.31
Dividend Yield3%
ROE9.66%
ROA478.33%
Revenue (TTM)
Revenue Growth1.63%
Profit Margin6.8%
Total Debt₹130 Cr
Shares Outstanding10 Cr
Face Value₹1
EPS (TTM)₹6.4
P/B5.79
Debt / Equity0.61
50 DMA₹368.6
200 DMA₹328.14
Day change+0.42%
Price Chart
383.95 5.09% · 1Y
40727483.5L
2025-07-30
2026-07-30

20-day avg volume: 1.1L shares

Pros
  • Pays a dividend yield of 3.0%.
  • Company is almost debt-free.
  • Net profit is growing year over year.
Cons
  • Stock trades at a high P/E of 176.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹203 Cr₹204 Cr₹208 Cr₹205 Cr₹224 Cr₹237 Cr₹231 Cr₹252 Cr
EBITDA₹33 Cr₹34 Cr₹31 Cr₹19 Cr₹27 Cr₹32 Cr₹26 Cr₹38 Cr
Net Profit₹21 Cr₹22 Cr₹19 Cr₹8 Cr₹13 Cr₹17 Cr₹12 Cr₹22 Cr
EPS
Profit & Loss (Annual)
MetricSept 2024Dec 2024Mar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹204 Cr₹208 Cr₹823 Cr₹205 Cr₹227 Cr₹230 Cr₹231 Cr₹252 Cr
EBITDA₹34 Cr₹31 Cr₹119 Cr₹19 Cr₹26 Cr₹30 Cr₹29 Cr₹37 Cr
Net Profit₹22 Cr₹19 Cr₹70 Cr₹8 Cr₹12 Cr₹15 Cr₹16 Cr₹21 Cr
EPS6.95
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹408 Cr₹392 Cr₹521 Cr₹861 Cr₹1,093 Cr₹1,169 Cr
Total Liabilities₹278 Cr₹219 Cr₹252 Cr₹513 Cr₹560 Cr₹568 Cr
Equity₹129 Cr₹173 Cr₹269 Cr₹348 Cr₹533 Cr₹601 Cr
Total Debt₹20 Cr₹35 Cr₹48 Cr₹191 Cr
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹97 Cr₹139 Cr₹1 Cr₹20 Cr₹145 Cr
Investing₹-7 Cr₹-95 Cr₹-191 Cr₹-102 Cr₹-71 Cr
Financing₹-79 Cr₹-6 Cr₹234 Cr₹82 Cr₹-37 Cr
Free Cash Flow₹97 Cr₹139 Cr₹1 Cr₹20 Cr₹145 Cr
Shareholding
Promoter 72.5% Institutions 4.14% Public 23.36%
Efficiency & Working Capital
ROCE12.9%
Interest Coverage4.8
Dividend Payout
Debtor Days140 d
Inventory Days97 d
Payable Days71 d
Cash Conversion Cycle166 d
Working Capital Days237 d
Shareholding Details

As of 2026-06-30

Promoter72.5%
FII0.5%
DII3.7%
Institutions4.1%
Public23.4%
Promoter Pledge0%
No. of Shareholders29,753
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodOct 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters72.5%72.5%72.5%72.5%72.5%72.5%72.5%72.5%72.5%72.5%72.5%72.5%
FIIs0.7%0.5%0.1%0.2%0.2%0.3%0.3%0.3%0.3%0.4%0.4%0.5%
DIIs1.6%1.6%2.2%2.4%2.5%3%3.4%3.4%3.7%3.7%3.8%3.7%
Public25.2%25.4%25.2%24.9%24.7%24.2%23.8%23.8%23.5%23.3%23.2%23.4%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders36,52434,42434,69532,25032,82533,29931,84431,87631,42030,36229,22329,753
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503
Major Shareholders (>1%)
NameCategoryStakeShares
Jayesh Pannalal ChoksiShareholding of Promoter and Promoter Group24.6%2.47 Cr
Zircon Teconica Private LimitedShareholding of Promoter and Promoter Group20.5%2.05 Cr
Gufic Private LimitedShareholding of Promoter and Promoter Group10.2%1.02 Cr
Vipula Jayesh ChoksiShareholding of Promoter and Promoter Group10%1.00 Cr
Pranav Jayesh ChoksiShareholding of Promoter and Promoter Group7.3%72,68,626
Motilal Oswal Financial Services LtdPublic Shareholding3.3%33,33,000
Icici Prudential Multicap FundPublic Shareholding2%20,25,385
Jagdish N MasterPublic Shareholding1.4%14,14,750
Jal Private LimitedShareholding of Promoter and Promoter Group0%0
Tricon Enterprises Private LimitedShareholding of Promoter and Promoter Group0%0
Motif Hotels LlpShareholding of Promoter and Promoter Group0%0
Fc Kingsmen LlpShareholding of Promoter and Promoter Group0%0
Gufic Chem Private LimitedShareholding of Promoter and Promoter Group0%0
Zire Realty LimitedShareholding of Promoter and Promoter Group0%0
Pooja Pranav ChoksiShareholding of Promoter and Promoter Group0%0
Meira Pranav ChoksiShareholding of Promoter and Promoter Group0%0
Shiv Pranav ChoksiShareholding of Promoter and Promoter Group0%0
Rita Ashok ShahShareholding of Promoter and Promoter Group0%0
Kshama Vipul ChoksiShareholding of Promoter and Promoter Group0%0
Forum Ameet ShahShareholding of Promoter and Promoter Group0%0
Jayesh Pannalal Choksi (huf)Shareholding of Promoter and Promoter Group0%0
Uma Lalit TrivediShareholding of Promoter and Promoter Group0%0
Dhan Pankaj ZaveriShareholding of Promoter and Promoter Group0%0
Deepika Milan BarotShareholding of Promoter and Promoter Group0%0
Pankaj Ramniklal PandyaShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
Jayesh P ChoksiChairman / Executive Director / M D / Promoter2025
Pranav J ChoksiED / WTD / CEO / Promoter2025
Pankaj GandhiWhole-time Director2025
Anusanjiv AuroraIndependent Non Exe. Director2025
Kamal Kishore SethIndependent Non Exe. Director2025
Akshya Kumar MahapatraIndependent Non Exe. Director2025
Ami Naresh ShahCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Pharma₹285 Cr93.8%
Bulk Drugs₹19 Cr6.2%
Segments — Geography
RegionRevenueShare
India₹654 Cr79.8%
Africa₹24 Cr2.9%
Asia₹50 Cr6%
Europe₹62 Cr7.5%
North America₹10 Cr1.2%
Australia₹1 Cr0.1%
South America₹19 Cr2.4%
Other₹0 Cr0%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹1111010
Corporate Actions
TypeDateValueRemark
dividend2025-09-22₹0.1 (10%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
20250002710
20250002710
2025000000
Insider / Designated-Person Trades

2 recent disclosure(s)

JAYESH CHOKSIDisposal · 18,000
JAYESH CHOKSIDisposal · 4,50,000
Substantial Acquisitions (SAST)

1 disclosure(s)

Market02/06/2022 · 4,68,000
Company Information
Incorporated1984
ChairmanJayesh P Choksi
AuditorMittal Agarwal & Company
Investor Email[email protected]; mgr_legal@guficbi
🌐 www.gufic.com

📍 Shop-37 1st Flr Kamala Bhavan, Swami Nityanand Road Andheri(E, Mumbai, Maharashtra, 400069

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search